Backed with $82 million and led by two of BioMarin’s former executives, Mendra plans to acquire rare disease assets and use ...

A Watertown biotech is suspending drug development and laying off essentially all of its workers in a bid to save cash and ...

The joint guidance was created to ensure drug developers employ best practices when using AI.

The Drug Information Association (DIA) today announced the launch of DIA ASCENT, a new global platform designed to support ...

AI and machine learning are revolutionizing drug discovery, development, and lifecycle management, addressing industry ...

The startup has partnered with Eli Lilly and enjoys the backing of some of Silicon Valley's most influential VCs.

BOSTON, Nov. 06, 2025 (GLOBE NEWSWIRE) -- BPGbio, Inc., a biology-first, AI-powered, clinical-stage biopharma focused on mitochondrial biology and protein homeostasis, today announced it has won the ...

The collaboration marks a turning point in AI-driven drug design and trial forecasting, de-risking the drug development ...

Delve into what 2026 has to offer in the biotech industry. The market is showing signs it's picking up and the patent cliff ...

Looking to overcome some of the limitations of existing obesity drugs, Alveus Therapeutics has debuted with nearly $160 million in hand and an impressive roster of executives ready to take the biot | ...

China quietly became biotech’s back-office, from molecule synthesis and clinical trials to novel drug licensing. Now the ...

FDA and EMA have issued 10 guiding principles for AI in drug development with the intended goal of ensuring safety and ...